Protection of Hepatic and Renal Function by Methotrexate Loading Erythrocytes in Hepatocarcinoma Rats

YUAN Sheng-hua,WANG Hao,GE Wei-hong,ZHANG Shang-suo
DOI: https://doi.org/10.3969/j.issn.1673-7806.2010.02.018
2010-01-01
Abstract:Objec tive:To observe the hepatic and renal functions of hepatoma bearing rats after the administration of methotrexate loading erythrocytes(MTX-RBCs).Methods:Thirty-two SD rats were randomly divided into 4 groups of the control,the model and the models with free MTX or MTX-RBCs injection.We monitored the body weight and survival time since the hepatoma model was formed by intrahepatic injection of walker 256 cells containing ascites.Eight days later,rat tumors were removed and measured.The serum samples were also kept for ALT,AST,BUN and Scr determination.Results:The hepatoma rat model was well built,and the MTX-RBCs venous injection could significantly prolong surviving time of rats with mild changes of body weights.Interestingly,compared with the free MTX injection,the MTX-RBCs injection also lowered ALT,AST,BUN and Scr levels and obviously reduced tumor volume in the same time.Conclusion:Intravenous injection of hyperosmotically prepared MTX-RBCs can inhibit tumor formation and perform well on protecting hepatic and renal function in experimental hepatoma bearing rats,thus be recognized as a safe and potential treatment.
What problem does this paper attempt to address?